Article
A single-center experience of post-transplant atypical hemolytic uremic syndrome.
Clinical nephrology - 1 Aug 2023
Abu Jawdeh Bassam G, Khan Muhammad A
Abstract excerpt
PURPOSE: Atypical hemolytic uremic syndrome (aHUS) is a genetic-based thrombotic microangiopathy (TMA) that is mediated by the activation of the alternative complement pathway. Heterozygous deletion in CFHR3-CFHR1 occurs in 30% of the general population and has not been classically linked to aHUS. Post-transplant aHUS has been associated with a high rate of graft loss. Herein, we report our case series of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
